TRANSPLANTING HUMAN BODY ORGANS FROM LIVING PERSONS IS A MULTI-BILLION DOLLAR BUSINESS (NOT JUST MEDICAL) AROUND THE WORLD. WHEN A VITAL ORGAN IS TRANSPLANTED, SUCH AS A HEART, THE DONOR DIES. ORGANS CANNOT BE TRANSPLANTED FROM A CORPSE, ONLY FROM A LIVING PERSON.

Global Organ and Tissue Transplantation Industry

PR NewswireMay 20, 2019

NEW YORK, May 20, 2019 /PRNewswire/ —

This report analyzes the worldwide markets for Organ and Tissue Transplantation in Volume Terms (Number of Procedures).



Download the full report: 
https://www.reportbuyer.com/product/5379582/?utm_source=PRN 



The Global and Regional markets (except the US) are analyzed by the following Product Segments: Heart, Kidney, Liver, Pancreas, and Lung, and Corneal Transplantation. The US market is analyzed by the following Segments: Organ Type (In Volume and Value) – Heart, Kidney, Liver, Pancreas, Lung, and Intestine; Tissue Type (Volume Only) – Cornea, Heart Valve, Skin Grafts, Vascular Grafts, Bone Marrow, and Bone Grafts; and Bone Graft Transplantation (Volume Only) -By Graft Type: Autologous Graft, Allograft, and Other Materials; and By Application Type: General Orthopedics, Spinal Fusions, and Cranio/Maxillofacial. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.

Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. 

The report profiles 19 companies including many key and niche players such as:
– Acelity L.P. Inc.
– CryoLife, Inc. 
– Exactech, Inc. 
– Dr. Franz Köhler Chemie GmbH 
– Organogenesis, Inc. 
– Organ Recovery Systems



Download the full report: https://www.reportbuyer.com/product/5379582/?utm_source=PRN 

ORGAN AND TISSUE TRANSPLANTATION MCP-1
MARKET ANALYSIS, TRENDS, AND FORECASTS, MAY 2
CONTENTS 

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 

Study Reliability and Reporting Limitations 
Disclaimers 
Data Interpretation & Reporting Level 
Quantitative Techniques & Analytics 
Product Definitions and Scope of Study 
Organ Transplantation 
Heart Transplantation 
Kidney Transplantation 
Liver Transplantation 
Pancreas Transplantation 
Small Intestine Transplantation 
Lungs 
Tissue Transplantation 
Corneal Transplantation 
Blood Stem Cell Transplantation 
Bone Marrow Transplantation 
Heart Valves Transplantation 

II. EXECUTIVE SUMMARY 


1. MARKET OVERVIEW 

Market Outlook 
Current & Future Analysis 
A Review of Organ Donors Worldwide 
Table 1: World Deceased Organ Donors (2016 & 2017): Number of Donors Per Million Population (PMP) for Leading Countries (includes corresponding Graph/Chart) 
Table 2: World Living Organ Donors (2016 & 2017): Number of Donors Per Million Population (PMP) for Leading Countries (includes corresponding Graph/Chart) 
Table 3: World Deceased Organ Donors by Type (2011, 2013 & 2015): Percentage Breakdown of Number of Donors for DCD and DBD (includes corresponding Graph/Chart) 
Demand and Supply Imbalance 
Measures to Address Organ Shortage 
Cardiac Arrest Death Patients: The Untapped Potential Donors 
Table 4: World Organ Donors After Circulatory Death (2016): Number of Donors Per Million Population (PMP) for Leading Countries (includes corresponding Graph/Chart) 
Donation after Circulatory Death – Rife with Ethical Issues 
Transplantation – Expenditure and Regional Variations 
Table 5: US Organ Transplantation Charges – Total Billed Charges per Transplant by Type (2014) (includes corresponding Graph/Chart) 
Bone Grafts: An Overview 
Table 6: Fractures by Age Group (2017E): Percentage Share Breakdown of Number of Fractures by Age Group (includes corresponding Graph/Chart) 
Orthopedic Grafts – Regional Market Variations 


2. MARKET TRENDS 

Combined Organ Transplantation – Gaining Attention 
Illegal Organ Trafficking – A Risky Proposition 
Transplant Tourism – Creating Brighter Avenues 
Graying Population and Chronic Diseases Surge Need for Transplants 
Table 7: Global Aging Population (in Thousands) by Age Group: 1975-2050 (includes corresponding Graph/Chart) 
Table 8: Global Aging Population in Select Regions/Countries: Population of 60+ Individuals in ‘000s and as a Percentage of Total Population for 2015 & 2050 (includes corresponding Graph/Chart) 
Table 9: Global Population Statistics for the 60+ Age Group by Region (2017) (includes corresponding Graph/Chart) 
Table 10: Global Life Expectancy at Birth (Years) by Geographic Region: 1950-2050 (includes corresponding Graph/Chart) 
Table 11: Life Expectancy for Select Countries in Number of Years: 2016 (includes corresponding Graph/Chart) 
Optimization Strategies for Organs Catch Attention and Supply – Demand Gap Widens 
Advent of Innovative Devices Mitigate Chances of Organ Damages 
Investment Opportunities Rise for Allied Fields as Organ Transplantation Market Grows 
Shortage of Organs Propels Research on Xenotransplantation 
A Peek into the Organ Transplant Immunosuppressants Market 
Market to Come Under Tremendous Pressure 
Rising Incidences of Degenerative Intervertebral Disc Diseases Promote Tissue Transplantation 
Table 12: % of Women Affected by Osteoporosis (includes corresponding Graph/Chart) 
Fetal Tissue for Bionic Devices – Assuming Importance 
LVADs – Gaining Significance for Impending Heart Transplants 
Synthetic Bone Graft – The Latest Trend 
Stem Cell Therapies – Expanding the Horizon of Transplantation 
Rising Cancer Incidence to Drive Stem Cell Transplants 
Table 13: Global Cancer Incidence (2015): Number of New Cancer Cases in Thousands by Type and Gender (includes corresponding Graph/Chart) 
Table 14: Global Cancer Mortality (2015): Number of Cancer Related Deaths in Thousands by Type and Gender (includes corresponding Graph/Chart) 
Demineralized Bone Matrix (DBM): Strong Growth but Tough Competition 
Bone Morphogenetic Protein – Safety Concerns Affect Growth Prospects 
Dental Bone Grafting – A High Potential Market 
Table 15: Dental Tissue & Bone Regeneration Materials Market (2015): Percentage Share Breakdown by Segment for Allografts, Synthetics, and Xenografts (includes corresponding Graph/Chart) 
Key Recent Technological Innovations 
3-D Bioprinting 
Preloaded Corneal Tissue Cartridges 
Lung Perfusion Technology 


3. MAJOR ISSUES IMPACTING TRANSPLANTATION MARKET 

Organ Rejection – A Major Barrier to Transplantation 
Scarcity of Donor Organs – A Stumbling Block in Organ Transplantation 
Other Issues for Organ Transplantation 
Ethical Concerns in Transplants 
Bioethical Issues Hinder Organ Donation Process 
Lack of Requisite Expertise – Hindering Implantation Process 
Corneal Transplantation in Developing Countries: Key Challenges 


4. PRODUCT OVERVIEW 

Organ and Tissue Transplantation 
Organ Transplantation 
Heart Transplantation 
Heart Diseases and Disorders 
Post-Operative Complications and Consequences of Heart Transplants 
Bleeding 
Infection 
Arrhythmia 
Heart Attack 
Coronary Artery Disease 
Respiratory Dysfunction 
Renal Dysfunction 
Graft Rejection and Dysfunction 
Death 
Kidney Transplantation 
Kidney Disorders and Diseases 
Donor Evaluation 
Waiting List 
Surgery/Post-Operation 
Post-Operative Supervision and Issues 
Liver Transplantation 
Liver Disorders and Diseases 
Pancreas Transplantation 
Post-Operative Complications and Consequences of Pancreas Transplants 
Small Intestine Transplantation 
Intestine Disorders and Diseases 
Lung Transplantation 
Lung Diseases and Disorders 
Lung Patients Survival Statistics 
Heart-and-Lung Transplantation 
Tissue Transplantation 
Types of Grafts 
Autograft 
Allograft/Homograft 
Transplant Tolerance 
Isograft 
Xenograft 
Corneal Transplantation 
Penetrating Keratoplasty 
Lamellar (Non-Penetrating) Keratoplasty 
Aftercare 
Risks Associated with Corneal Transplants 
Transplantation Outcomes 
Morbidity and Mortality Rates 
Alternatives 
Blood Stem Cells 
Peripheral Blood Stem Cell Transplant 
Umbilical Cord Blood Stem Cell Transplant 
Bone Marrow and Hematopoietic Stem Cells 
Bone and Tissue Transplantation 
Bone Marrow Transplants 
Stem Cell Therapy 
Human Heart Valves 
Atrioventricular Valves 
Mitral Valve 
Tricuspid Valve 
Semilunar Valves 
Aortic Valve 
Pulmonic Valve 
Pathology of Valves 
Prosthetic Heart Valves 
Prosthetic Mechanical Valve 
Advantages 
Disadvantages 
Prosthetic Biologic Valve 
Advantages 
Disadvantages 
Fetal Cells 
Fetal Tissue for Transplantation 
Storage Duration Time 
Storage Time Period for Organs and Tissues 
Cold Ischemia Time 
Transplantation Immunology 
Acute Cellular Rejection 
Chronic Rejection 
Post-Transplant Observations 
Types of Donors 
Alive Donors 
Related Donors 
Good Samaritans 
Rewarded/Forced Donors 
Deceased Donors 
Directed / Allocated 
Organs and Tissues Transplanted by Type of Donor 
Organ/Tissue Donation and Eligibility Criteria 
Factors Considered for Matching Recipients to Donor Organs 
Testing 
Blood Typing 
Tissue Typing 
Histocompatibility – A Major Barrier for Organ Transplantation 
Transplantation – Safety Requirements 
Waiting List 
Active Waiting List Patients 
Inactive Waiting List Patients 
History 
Major Milestones in Organ Transplantation 


5. ARTIFICIAL ORGANS – AN ALTERNATIVE TO SOLID ORGAN TRANSPLANTS 

Artificial Organs Revolutionize Medical Technology Industry 
Artificial Organs 
Categorization of Artificial Organs 
External Artificial Organs 
Internal or Implantable Artificial Devices 
Artificial Heart 
Total Artificial Heart (TAH) 
Ventricle Assist Device (VAD) 
Right Ventricular Assist Systems (RVAS) 
Left Ventricular Assist Systems (LVAS) 
Select Ventricular Assist Devices 
Artificial Kidney (Dialyzer) 
Limitations of Artificial Kidney 
Artificial Liver 
Select Liver Assist Devices 
Categorization of Liver Devices 
Mechanical Systems 
Bio-Artificial Systems 
Artificial Pancreas 
Artificial Lungs (Oxygenator) 
Types of Artificial Lung 
Artificial Cornea 
Keratoprostheses 
Tissue Engineered Corneas 
Artificial Skin/Skin Replacement Products 
AlloDerm Regenerative Tissue Matrix 
Apligraf 
Cymetra Micronized AlloDerm Tissue 
Dermagraft 
Epicel 
Integra Products 
OrCel 
TransCyte 
Core Competitive Factors 
Market Outlook for Artificial Organs 


6. PRESERVATION SOLUTIONS & IMMUNOSUPPRESSANT DRUGS 

Organ Preservation Solutions 
Celsior Solution 
Collins Solution 
Euro Collins Solution 
Custodiol® HTK Solution 
Hypothermosol 
ViaSpan 
Immunosuppressant Drugs 
Antibody Products for Treatment of Organ Transplant Rejection 
Antithymocyte Globulin 
ATGAM 
Thymoglobulin 
Therapeutic Antibody Products 
Antiproliferative Agents 
Azathioprine 
CellCept 
Certican 
Myfortic 
Calcineurin Inhibitors 
Cyclosporine 
Gengraf 
Neoral 
Prograf (Tacrolimus) 
TOR Inhibitors 
Side Effects of Immunosuppression Therapy 


7. REGULATORY ENVIRONMENT 

Transplant Center 
Organ Procurement Organization (OPO) 
Health Resources and Services Administration (HRSA) 
Division of Transplantation (DoT) 
United Network for Organ Sharing (UNOS) 
Organ Procurement and Transplantation Network (OPTN) 
University Renal Research and Education Association (URREA) 
Scientific Registry of Transplant Recipients (SRTR) 
Funding Sources 
Patient Education and Advocacy Organizations 
Legal Framework for Transplantation 
Legislation Covering Organ Transplant 
Organ Transplantation and Ethics 


8. PRODUCT LAUNCHES 

Royal Biologics Launches Demineralized Bone Matrix Product, MAXX-Fuse 
Extremity Medical Launches Next-Gen Viable Cell Bone Graft, BioFuse 
AlloSource Launches Two New Demineralized Cortical Fiber Allografts 
Immucor Launches Kidney Solid Organ Response Test, kSORT 


9. RECENT INDUSTRY ACTIVITY 

Exactech Merges with TPG Capital 
CryoLife Acquires JOTEC 
SeaSpine Receives FDA Approval for OsteoBallast™ DBM in Resorbable Mesh 
Medtronic Receives FDA Approval for Endurant™ II/IIs Stent Graft System 
Organogenesis Acquires NuTech Medical 
Allergan to Acquire Acelity’s LifeCell Business Unit 
CryoLife Acquires On-X Life Technologies 
MiMedx Group Acquires Stability Biologics 


10. FOCUS ON SELECT PLAYERS IN ALLIED AREAS 

Acelity L.P. Inc. (USA) 
CryoLife, Inc. (USA) 
Exactech, Inc. (USA) 
Dr. Franz Köhler Chemie GmbH (Germany) 
Organogenesis, Inc. (USA) 
Organ Recovery Systems (USA) 
Organ Transport Systems (USA) 
XVIVO Perfusion AB (Sweden) 


11. GLOBAL MARKET PERSPECTIVE 

Table 16: World Recent Past, Current & Future Analysis for Organ Transplantation by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart) 
Table 17: World Historic Review for Organ Transplantation by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart) 
Table 18: World 14-Year Perspective for Organ Transplantation by Geographic Region – Percentage Breakdown of Number of Procedures for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart) 
Table 19: World Recent Past, Current & Future Analysis for Heart Transplantation by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart) 
Table 20: World Historic Review for Heart Transplantation by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart) 
Table 21: World 14-Year Perspective for Heart Transplantation by Geographic Region – Percentage Breakdown of Number of Procedures for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart) 
Table 22: World Recent Past, Current & Future Analysis for Kidney Transplantation by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart) 
Table 23: World Historic Review for Kidney Transplantation by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart) 
Table 24: World 14-Year Perspective for Kidney Transplantation by Geographic Region – Percentage Breakdown of Number of Procedures for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart) 
Table 25: World Recent Past, Current & Future Analysis for Liver Transplantation by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart) 
Table 26: World Historic Review for Liver Transplantation by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart) 
Table 27: World 14-Year Perspective for Liver Transplantation by Geographic Region – Percentage Breakdown of Number of Procedures for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart) 
Table 28: World Recent Past, Current & Future Analysis for Pancreas Transplantation by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart) 
Table 29: World Historic Review for Pancreas Transplantation by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart) 
Table 30: World 14-Year Perspective for Pancreas Transplantation by Geographic Region – Percentage Breakdown of Number of Procedures for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart) 
Table 31: World Recent Past, Current & Future Analysis for Lung Transplantation by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart) 
Table 32: World Historic Review for Lung Transplantation by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart) 
Table 33: World 14-Year Perspective for Lung Transplantation by Geographic Region – Percentage Breakdown of Number of Procedures for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart) 
Table 34: World Recent Past, Current & Future Analysis for Corneal Transplantation by Geographic Region – US, Canada, Europe, Asia-Pacific (including Japan), Latin Americaand Rest of World Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart) 
Table 35: World Historic Review for Corneal Transplantation by Geographic Region – US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart) 
Table 36: World 14-Year Perspective for Corneal Transplantation by Geographic Region – Percentage Breakdown of Number of Procedures for US, Canada, Europe, Asia-Pacific(including Japan), Latin America and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart) 

III. MARKET 


1. THE UNITED STATES 

A.Market Analysis 
Current & Future Analysis 
Organ Transplant Sector Holds Growth Potential 
Table 37: Number of Transplants and Waiting List for Organ Transplantation in the US: 2005 & 2016 (In Thousands) (includes corresponding Graph/Chart) 
Table 38: Organ Transplantation Donors in the US by Type (2016): Number of Organ Donors in Thousands and Percentage Share Breakdown for Living and Deceased (includes corresponding Graph/Chart) 
Table 39: Organs Donated for Transplantation in the US by Type (2016): Number of Donated Organs in Thousands and Percentage Share Breakdown for Living and Deceased (includes corresponding Graph/Chart) 
Table 40: US Deceased Donors by Ethnicity (2016): Percentage Breakdown of Number of Donors for African America, Asian, Caucasian, Hispanic and Others (includes corresponding Graph/Chart) 
Table 41: Transplant Recipients in the US by Ethnicity (2016): Percentage Breakdown of Number of Transplants for African America, Asian, Caucasian, Hispanic and Others (includes corresponding Graph/Chart) 
Waiting List for Organ Transplants in the US 
Table 42: Organ Transplant Waiting List in the US by Ethnicity (2017): Percentage Breakdown of Number of People on Waiting List for African America, Asian, Caucasian, Hispanic and Others (includes corresponding Graph/Chart) 
Select Market Trends 
Rising Incidence of ESRD in the US: A Business Case for Kidney Transplants 
Innovative Education Programs Contribute to Higher Organ Donors 
Awareness Programs to Address Shortage of Minority Donors 
US Organ Procurement Organizations by State 
KPD Enables Compatibility Factor for Kidney Transplants 
Tissue Transplantation in the US 
Dental Bone Graft Substitutes Market: An Overview 
Regulatory Challenges Limit Growth in the US Orthopedic Biomaterials Market 
Rising Incidence of Degenerative Intervertebral Disc Diseases – Opportunity Indicators for Bone Grafts 
Osteoporosis 
Table 43: Osteoporosis and Low Bone Mass Population in the US: 2010 & 2020 (includes corresponding Graph/Chart) 
Table 44: Breakdown of Osteoporotic Fractures by Site in the US (includes corresponding Graph/Chart) 
Regulatory Bodies 
The United Network for Organ Sharing 
The American Association of Tissue Banks (AATB) 
Accredited Banks from Select US States 
Eye Banks from Select US States 
National Organ Transplant Act (NOTA) 
Good Tissue Practices 
Tissue Banking Regulation 
FDA Regulations on Xenograft 
DBM-based Products in US 
Synthetic Bone Graft Substitutes 
Product Launches 
Strategic Corporate Developments 
Select Key Players 
B.Market Analytics 
By Value Sales 
Table 45: The US Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type – Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2
through 2024 (includes corresponding Graph/Chart) 
Table 46: The US Historic Review for Organ Transplantation by Organ Type – Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2
(includes corresponding Graph/Chart) 
Table 47: The US 14-Year Perspective for Organ Transplantation by Organ Type – Percentage Breakdown of Dollar Sales for Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart) 
Table 48: The US Recent Past, Current & Future Analysis for Cornea Transplantation Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2
(includes corresponding Graph/Chart) 
Table 49: The US Historic Review for Cornea Transplantation Market Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) 
By Number of Procedures 
Table 50: The US Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type – Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets Independently Analyzed with Number of Procedures for Years 2016 through 2
(includes corresponding Graph/Chart) 
Table 51: The US Historic Review for Organ Transplantation by Organ Type – Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart) 
Table 52: The US 14-Year Perspective for Organ Transplantation by Organ Type – Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets for Years 2011, 2017 & 2
(includes corresponding Graph/Chart) 
Table 53: The US Recent Past, Current & Future Analysis for Tissue Transplantation by Tissue Type – Cornea, Heart, Skin Grafts, Vascular Grafts, Bone Marrow and Bone Grafts Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart) 
Table 54: The US Historic Review for Tissue Transplantation by Tissue Type – Cornea, Heart, Skin Grafts, Vascular Grafts, Bone Marrow and Bone Grafts Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart) 
Table 55: The US 14-Year Perspective for Tissue Transplantation by Tissue Type – Percentage Breakdown of Number of Procedures for Cornea, Heart, Skin Grafts, Vascular Grafts, Bone Marrow and Bone Grafts Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart) 
Table 56: The US Recent Past, Current & Future Analysis for Bone Graft Transplantation by Graft Type – Autologous Graft, Allograft and Other Materials Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart) 
Table 57: The US Historic Review for Bone Graft Transplantation by Graft Type – Autologous Graft, Allograft and Other Materials Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart) 
Table 58: The US 14-Year Perspective for Bone Graft Transplantation by Graft Type – Percentage Breakdown of Number of Procedures for Autologous Graft, Allograft and Other Materials Markets for Years 2011, 2017 & 2
(includes corresponding Graph/Chart) 
Table 59: The US Recent Past, Current & Future Analysis for Bone Graft Transplantation by Application – General Orthopedics, Spinal Fusions and Cranio/Maxillofacial Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart) 
Table 60: The US Historic Review for Bone Graft Transplantation by Application – General Orthopedics, Spinal Fusions and Cranio/ Maxillofacial Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart) 
Table 61: The US 14-Year Perspective for Bone Graft Transplantation by Application – Percentage Breakdown of Number of Procedures for General Orthopedics, Spinal Fusions and Cranio/ Maxillofacial Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart) 


2. CANADA 

A.Market Analysis 
Current & Future Analysis 
Canadians More Receptive to Organ Transplants 
Table 62: Organ Transplants in Canada by Province (2016): Percentage Breakdown of Number Transplants for Alberta, British Columbia, Manitoba, Ontario, Quebec, Saskatchewan and Others (includes corresponding Graph/Chart) 
Table 63: Combination Organ Transplants in Canada by Province (2016): Percentage Breakdown of Number Transplants for Alberta, British Columbia, Ontario and Quebec(includes corresponding Graph/Chart) 
Table 64: Combination Organ Transplants in Canada by Combination (2016): Percentage Breakdown of Number Transplants for Heart-Lung, Kidney-Liver, Kidney-Pancreas, Liver-Small Intestine, Multi-visceral Cluster and Others (includes corresponding Graph/Chart) 
Organ Donors 
Table 65: Canadian Organ Donors by Donor Type – Deceased and Living for Years 2012-2016 (includes corresponding Graph/Chart) 
Table 66: Living Donor Transplants in Canada by Organ (2016): Percentage Breakdown of Number of Transplants for Kidney, Kidney Paired Donation, and Liver (includes corresponding Graph/Chart) 
Table 67: Deceased Organ Donations in Canada (2016): Organ Donations Per Million Population (PMP) by Province (includes corresponding Graph/Chart) 
Waiting List 
Table 68: Organ Transplantation Waiting List in Canada (2016): Number of Patients on Waiting List by Organ Type – Heart, Kidney, Liver, Lung, Pancreas and Others (includes corresponding Graph/Chart) 
Table 69: Waiting List Trends in Recent Past (2012-2016): Number of Patients on Waiting List for Heart, Kidney, Liver and Lung Transplantation (includes corresponding Graph/Chart) 
Table 70: Combination Organ Transplants Waiting List in Canada by Combination (2016): Percentage Breakdown of Number Transplants for Heart-Lung, Heart-Liver, Kidney-Heart, Kidney-Pancreas, Kidney-Liver, Liver-Lung, Liver-Small Intestine and Others (includes corresponding Graph/Chart) 
Favorable Growth Prospects in Bone Graft Substitutes Market 
B.Market Analytics 
Table 71: Canadian Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type – Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart) 
Table 72: Canadian Historic Review for Organ Transplantation by Organ Type – Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart) 
Table 73: Canadian 14-Year Perspective for Organ Transplantation by Organ Type – Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart) 


3. JAPAN 

A.Market Analysis 
Current & Future Analysis 
Terumo Corporation (Japan) – A Key Player 
B.Market Analytics 
Table 74: Japanese Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type – Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart) 
Table 75: Japanese Historic Review for Organ Transplantation by Organ Type – Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart) 
Table 76: Japanese 14-Year Perspective for Organ Transplantation by Organ Type – Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart) 


4. EUROPE 

A.Market Analysis 
Current & Future Analysis 
Key Statistics 
Table 77: European Organ Transplantation Rate in Per Million Population for Leading Countries: 2016 (includes corresponding Graph/Chart) 
Table 78: European Deceased Organ Donors Per Million Population (PMP) in Select Leading Countries: 2
(includes corresponding Graph/Chart) 
Table 79: European Living Organ Donors Per Million Population (PMP) in Select Leading Countries: 2
(includes corresponding Graph/Chart) 
Policy Changes – Key to Bridge Variability in Kidney Donors and Transplants across Europe 
B.Market Analytics 
Table 80: European Recent Past, Current & Future Analysis for Organ Transplantation by Geographic Region – France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart) 
Table 81: European Historic Review for Organ Transplantation by Geographic Region – France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Number of Procedures for Years 2011 through 2
(includes corresponding Graph/Chart) 
Table 82: European 14-Year Perspective for Organ Transplantation by Geographic Region – Percentage Breakdown of Number of Procedures for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart) 
Table 83: European Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type – Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart) 
Table 84: European Historic Review for Organ Transplantation by Organ Type – Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart) 
Table 85: European 14-Year Perspective for Organ Transplantation by Organ Type – Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart) 

4a. FRANCE 
A.Market Analysis 
Current & Future Analysis 
Organ Donation Statistics 
Table 86: Organ Donations in France (2016): Number of Donors and PMP by Type – Deceased and Living (includes corresponding Graph/Chart) 
B.Market Analytics 
Table 87: French Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type – Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart) 
Table 88: French Historic Review for Organ Transplantation by Organ Type – Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart) 
Table 89: French 14-Year Perspective for Organ Transplantation by Organ Type – Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart) 

4b. GERMANY 
A.Market Analysis 
Current & Future Analysis 
Strategic Corporate Development 
Key Player 
B.Market Analytics 
Table 90: German Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type – Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart) 
Table 91: German Historic Review for Organ Transplantation by Organ Type – Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart) 
Table 92: German 14-Year Perspective for Organ Transplantation by Organ Type – Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart) 

4c. ITALY 
A.Market Analysis 
Current & Future Analysis 
Surge in Organ Transplants 
Table 93: Organ Donations in Italy (2016): Number of Donors and PMP by Type – Deceased and Living (includes corresponding Graph/Chart) 
B.Market Analytics 
Table 94: Italian Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type – Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart) 
Table 95: Italian Historic Review for Organ Transplantation by Organ Type – Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart) 
Table 96: Italian 14-Year Perspective for Organ Transplantation by Organ Type – Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart) 

4d. THE UNITED KINGDOM 
A.Market Analysis 
Current & Future Analysis 
Organ Transplantation in the UK 
Key Statistics 
Table 97: Organ Donation in the UK by Type: Number of Deceased and Living Donors for Years 2012-13 through 2016-17 (includes corresponding Graph/Chart) 
Table 98: Deceased Organ Donors in the UK by Organ and Country (2017): Number of Organ Donors for England, Scotland, Wales and Northern Ireland (includes corresponding Graph/Chart) 
Table 99: Organ Transplantation Waiting List in the UK by Organ and Country (2017): Number of People on Waiting List for England, Scotland, Wales and Northern Ireland(includes corresponding Graph/Chart) 
Table 100: Deceased Solid Organ Donors in the UK by Organ Type and Type of Death: 2016-17 (includes corresponding Graph/Chart) 
Table 101: Organs Retrieved per Deceased Donor by Country (2016-17): Average Number of Organs Retrieved from Deceased Patients of all Ages for England, Wales, Scotland and Northern Ireland (includes corresponding Graph/Chart) 
Table 102: Organ Donors in the UK by Age Group and Death Type: 2016-17 (includes corresponding Graph/Chart) 
The UK Organ Transplantation System: An Overview 
B.Market Analytics 
Table 103: UK Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type – Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart) 
Table 104: UK Historic Review for Organ Transplantation by Organ Type – Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart) 
Table 105: UK 14-Year Perspective for Organ Transplantation by Organ Type – Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart) 

4e. SPAIN 
A.Market Analysis 
Current & Future Analysis 
Spain – A Global Leader in Organ Donation 
B.Market Analytics 
Table 106: Spanish Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type – Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart) 
Table 107: Spanish Historic Review for Organ Transplantation by Organ Type – Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart) 
Table 108: Spanish 14-Year Perspective for Organ Transplantation by Organ Type – Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart) 

4f. RUSSIA 
A.Market Analysis 
Current & Future Analysis 
Organ Transplantations Show a Downward Trend in Russia 
Organ Donation Statistics 
Table 109: Organ Donations in Russia (2016): Number of Donors and PMP by Type – Deceased and Living (includes corresponding Graph/Chart) 
B.Market Analytics 
Table 110: Russian Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type – Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart) 
Table 111: Russian Historic Review for Organ Transplantation by Organ Type – Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart) 
Table 112: Russian 14-Year Perspective for Organ Transplantation by Organ Type – Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart) 

4g. REST OF EUROPE 
A.Market Analysis 
Current & Future Analysis 
Turkey 
Table 113: Turkey – High PMP Numbers of Living Organ Donors/Transplants (includes corresponding Graph/Chart) 
Table 114: Organ Donations in Turkey (2016): Number of Donors by Type – Deceased and Living (includes corresponding Graph/Chart) 
Akdeniz University – A World-Renowned Transplantation Center 
Strategic Corporate Development 
Key Player 
B.Market Analytics 
Table 115: Rest of European Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type – Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart) 
Table 116: Rest of European Historic Review for Organ Transplantation by Organ Type – Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart) 
Table 117: Rest of European 14-Year Perspective for Organ Transplantation by Organ Type – Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart) 


5. ASIA-PACIFIC 

A.Market Analysis 
Current & Future Analysis 
Table 118: Asia-Pacific Deceased Organ Donor Per Million Population (PMP) by Country for 2013 & 2016 (includes corresponding Graph/Chart) 
Table 119: Asia-Pacific Living Organ Donor Per Million Population (PMP) by Country for 2012, 2014 & 2016 (includes corresponding Graph/Chart) 
Thriving Orthopedic Biomaterials Market in Asia-Pacific 
Focus on Select Regions 
Australia – One of the Major Organ Transplant Markets in Asia-Pacific 
Key Facts on Organ and Tissue Transplantation in Australia 
Organ Transplantations Reach Record Highs 
Table 120: Organ Donations in Australia (2016 & 2017): Number of Organ Donors by Type – Deceased (DBD and DCD) and Living (AKX and Others) (includes corresponding Graph/Chart) 
Table 121: Organs and Tissue Donor Volume in Australia by Type: 2017 (includes corresponding Graph/Chart) 
Table 122: Deceased Organ Donors and Donor PMP in Australia by State: 2017 (includes corresponding Graph/Chart) 
Table 123: Organ Transplantations Volume in Australia by Organ: 2016 & 2017 (includes corresponding Graph/Chart) 
Table 124: Tissue Donations in Australia (2016 & 2017): Number of Deceased Tissue Donations by Type – Musculoskeletal, Cardiovascular and Skin (includes corresponding Graph/Chart) 
Government Efforts Key for Improving Organ Donation Activity 
Government Mulls Easing Registration Process Further 
China 
Chinese Organ Transplant Market – Embroiled in Controversy 
A New and Promising Legal Organ Transplantation Set Up Emergence in China 
Transplantation Tourism in China 
Low Transplant Success Rate Due to Unskilled Professionals 
Illegal Activities for Harvesting Organs in China 
Regulations on Organ Transplantation 
Regulations on Brain Death 
India 
Organ Transplantation in India – Present Status 
Rise in Medical Tourism Drives Bone Grafts Market 
Aging Population Boosts the Indian Orthopedic Market 
The Current Status of Organ Donation and Transplantation 
Overview of Renal Transplantation 
Structural Deficiencies Affecting Indian Organ Donation Space 
Singapore 
Awareness Programs to Increase Living Kidney Donations in Singapore 
B.Market Analytics 
Table 125: Asia-Pacific Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type – Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart) 
Table 126: Asia-Pacific Historic Review for Organ Transplantation by Organ Type – Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart) 
Table 127: Asia-Pacific 14-Year Perspective for Organ Transplantation by Organ Type – Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart) 


6. LATIN AMERICA 

A.Market Analysis 
Current & Future Analysis 
Dental Bone Graft Substitutes Market – Overview 
Key Statistics 
Table 128: Latin American Deceased and Living Organ Donors Per Million Population (PMP) by Country: 2016 (includes corresponding Graph/Chart) 
B.Market Analytics 
Table 129: Latin American Recent Past, Current & Future Analysis for Organ Transplantation by Geographic Region – Brazil and Rest of Latin America Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart) 
Table 130: Latin American Historic Review for Organ Transplantation by Geographic Region – Brazil and Rest of Latin America Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart) 
Table 131: Latin American 14-Year Perspective for Organ Transplantation by Geographic Region – Percentage Breakdown of Number of Procedures for Brazil and Rest of Latin America Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart) 
Table 132: Latin American Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type – Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart) 
Table 133: Latin American Historic Review for Organ Transplantation by Organ Type – Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart) 
Table 134: Latin American 14-Year Perspective for Organ Transplantation by Organ Type – Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart) 

6a. BRAZIL 
A.Market Analysis 
Current & Future Analysis 
Brazil – A Major Transplant Market 
B.Market Analytics 
Table 135: Brazilian Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type – Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart) 
Table 136: Brazilian Historic Review for Organ Transplantation by Organ Type – Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart) 
Table 137: Brazilian 14-Year Perspective for Organ Transplantation by Organ Type – Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart) 

6b. REST OF LATIN AMERICA 
Market Analysis 
Table 138: Rest of Latin American Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type – Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart) 
Table 139: Rest of Latin American Historic Review for Organ Transplantation by Organ Type – Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart) 
Table 140: Rest of Latin American 14-Year Perspective for Organ Transplantation by Organ Type – Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart) 


7. REST OF WORLD 

Market Analysis 
Table 141: Rest of World Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type – Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart) 
Table 142: Rest of World Historic Review for Organ Transplantation by Organ Type – Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart) 
Table 143: Rest of World 14-Year Perspective for Organ Transplantation by Organ Type – Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart) 

IV. COMPETITIVE LANDSCAPE 

Total Companies Profiled: 
The United States (16) Europe (3) – Germany (1) – Rest of Europe (2) 
Download the full report: https://www.reportbuyer.com/product/5379582/?utm_source=PRN 

About Reportbuyer 
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers 

For more information: 
Sarah Smith 
Research Advisor at Reportbuyer.com 
Email: sarah@reportbuyer.com 
Tel: +1 (718) 213 4904 
Website: www.reportbuyer.com

Cision

View original content:http://www.prnewswire.com/news-releases/global-organ-and-tissue-transplantation-industry-300853391.html

About abyssum

I am a retired Roman Catholic Bishop, Bishop Emeritus of Corpus Christi, Texas
This entry was posted in Uncategorized. Bookmark the permalink.